Questions discussed in this category
There seems to be a wide variety of palliative doses used in clinical practice (8 Gy x1, 2 Gy x2, and 20 Gy in 10 fx). Do you have a preferred dose? D...
For example, a large iliac or sacral plasmacytoma causing symptoms. Both medical oncologists and radiation oncologists get nervous about RT-related cy...
Per the NCCN guideline for HR HD, if treated per OEPA-COPDAC, you can omit ISRT. This patient received treatment per AHOD1331, which recommends ISRT f...
Would you change your radiation therapy treatment dose or volume if you needed to treat a chloroma? If a patient had a separate cancer (e.g., skin can...
I am not sure there is much efficacy for a regimen that does not include asparaginase. The patient received 2 cycles of P-GemOx, then was admitted for...
What would be your RT volumes and dose?
How do you advise patients who strongly desire chemotherapy?
The patient has a history of a lymphoplasmacytic lymphoma with a CR after chemotherapy but presented with a large frontal lobe mass that was biopsied ...
For example, would you offer 4 Gy x 5 fx (vs 24 Gy/12 fx) in a patient with isolated recurrent follicular lymphoma of the breast after RCHOP and maint...
Would you offer palliative (4 Gy) radiation therapy to the stomach mass vs. definitive doses (24 - 30 Gy) encompassing all of the disease?
If a patient had a high dose of radiation to the spleen (10 Gy over 5 fractions) over a year ago but with increasing splenomegaly now, would you consi...
Does the stage at diagnosis affect your decision?
Given pelvic RT is likely to induce ovarian dysfunction/menopause, would you consider systemic options?
There was a recall on viscous lidocaine and many of our patients cannot find it. What would you recommend as alternatives?
What field design and dosing is most appropriate? Would you use ISRT or a more extended field?
Would you consider observation following surgical resection with negative margins? Would you recommend WBRT and/or ISRT? What would be your preferred ...
Specifically, do you offer closer follow-up for certain patients after local radiation?
Complete response was achieved after cycle 3. What extent of bone would you include?
Would you follow an algorithm such as the one proposed by Hall et al., PMID 29940062?How do you decide between intrathecal chemotherapy vs systemic th...
How do you counsel patients and caregivers? Do you prescribe medications (''appetite stimulants'') with the goal to improve appetite even if they do n...
In what situations would you feel comfortable omitting RT to bulky disease in stage III/IV Hodgkin's lymphoma?
Initial tumor size:18 cm. Partial response was achieved after cycle 2 and cycle 6 of chemotherapy. Complete response (Deauville 2, size: 6 cm) was ach...
Is there benefit to radiation on top of systemic therapy?
Would your management be different in node + vs. node - patients? What would be your radiation volume and dose?
Are you concerned about cases where radiation has to be started urgently before leukapheresis?
If the mesentery is widely involved with small lesions would this change your management? What if the patient was symptomatic?
Would you offer WBRT + boost vs WBRT vs focal treatment/SRS.
What influences your decision to proceed with palliative vs. definitive, and standard vs. hypofractionation dosing regimens?
Do you give RT before or after systemic therapy?
Does the fact that the patient is on methotrexate alter your choice?
How many cycles of systemic therapy is recommended? is XRT needed and what XRT dose is recommended?
How do you pursue fertility preservation in younger females with this presentation?
How would these expansions differ based on the anatomic site being treated?
What XRT dose do you use? Does the location of the disease (e.g., mediastinum) affect your decision when taking toxicity into account? would you offer...
Please specify how your institution is allocating resources now or will be soon.
Is this considered a sanctuary site from systemic therapy?
This is an adult patient that is status-post orchiectomy and R-CHOP now requiring prophylactic contralateral testicular radiation. Would you recommend...
Good performance score, 7 cm in size, CSF cytology is negative, MRI complete spine is negative. Would you consider any additional systemic therapy mod...
Elderly patient with large fungating necrotic breast mass positive for high grade BCL and a solitary hypermetabolic ipsilateral axillary node. Medical...
This is a recently described entity with poor prognosis, so even with a CR after RCHOPx6 cycles, is your bias to push for ISRT due to EBV being poor p...
Would you cover the lacrimal gland alone or the entire orbit?
She was on surveillance after lumpectomy. No prior radiation therapy. What dose/fractionation?
When would you treat the entire orbit versus partial orbit? One patient has medial rectus involvement and another has only conjunctival involvement. I...
Imaging studies (MRI and PET) show bilateral disease
Are there particular indications you use for RT? i.e. multiply recurrent, refractory to other therapies, near critical structures, unresectable (or re...
If so, how long before/after radiation?
What if the patient has had a liver transplant?
iPET2 and iPET4 showed Deauville 5 response. CT biopsy after 4 cycles was negative. Patient is currently scheduled for 2 additional cycles of ABVD.
Would you treat as bulky or non-bulky? Is ISRT indicated? Biopsy was performed because there was concern for soft tissue sarcoma.
What treatment margins/set-up/on-board imaging would you use?
If radiation is indicated, what dose would you use?
My experience has been that patients can be neurologically devastated years out from WBRT. In Medical Oncology practice at my institution, we do not r...
Do you use a cutoff of 10 cm? Do you measure the size of the largest node or measure the largest conglomerate or measure the total length of the entir...
The said patient has been on Imatinib for 2.5 years and is In MMR. Last rt-PCR was 0.04.
In this case, initial tumor was 9.5 cm craniocaudal but hardware spans the entire femur.
Signs/symptoms and echo/EKG consistent with pericardial effusion likely secondary to acute pericarditis
Does this change depending on stage?
Would you consider radiation therapy? What dose/fractionation?
Would 5000 cGy ISRT be appropriate? Would you include the entire maxilla to 3000 cGy and cone down or just treat the post incisional biopsy site...
Which systemic agents would you recommend holding during RT?
If re-irradiation, what dose would you use?
If the plasmacytoma was originally limited to the femoral neck, is it necessary to cover the entire femur out of concern for marrow space involvement?
In situations when we are waiting for insurance clearance or due to other logistical reasons.
Plasmacytoma of 6th rib s/p resection. Negative multiple myeloma work-up.
If the patient cannot tolerate methotrexate or further chemotherapy, how effective is radiation therapy (e.g. WBRT) in rendering the patient disease-f...
Would chemotherapy be preferred over RT?
NCCN only recommends palliative ISRT for non-transplant eligible patients with refractory/relapsed DLBCL
The dosing in the literature has a huge range.
If so, what dose and fractionation would you recommend?
Would you move straight to second-line systemic therapy or first attempt consolidative ISRT/boost, or employ both? Assume node is biopsy-proven.
If the patient has received RCHOPx3 and the post treatment PET is negative, what would your management be?
Would your recommendation change based on grade and/or location (weight-bearing vs non weight-bearing bone)?
Would your recommendations change if the mass were significantly smaller, say 1-2 cm, and was completely excised with negative margins?
Should systemic therapy or ISRT be utilized? Is there a risk for intrabdominal spread with perforation? If the ulcer is repaired by simple...
Would you consider ISRT after 3 cycles of RCHOP, omit radiation and proceed to surgery after 6 cycles of RCHOP, or do something else?
Specifically, would you consolidate initially bulky sites or allow patient to proceed to next line systemic therapy / transplant?
The patient was started immediately on chemotherapy due to gastric bleed and scrotal irradiation is planned.
In particular, for frail patients to avoid toxicity or for those that do not want chemotherapy
The patient in question has Stage IIIA DLBCL with a CR after 6 cycles R-CHOP. When would you treat the involved tonsil?
PET/CT negative for any other sites of metastatic disease. Focal activity noted on PET (postop changes?). CSF negative. Bone marrow biopsy negative. 2...
Does your recommendation change based on whether the patient has one or multiple lesions?
Would it being non-bulky and along the right heart border impact your decision making?
How do you approach systemic therapy options? What are your recommended volumes?
Would you offer refractory doses (40-50 Gy) to the RPnodes and send for splenectomy? Or would you offer refractory doses to both RP nodes and spleen?&...
Specifically, are there strategies you use to 1) empower patients to participate in decision-making and 2) reassure patients who may be skeptical?
Do you use specific tools or take into account certain factors when considering treatment options for older adults?
For example, in a patient treated with multiple systemic therapies over ~10 years, would it be reasonable to use radiation to a single asymptomatic si...
If so, what is your time threshold for when you'll start PCP prophylaxis--when you anticipate steroid courses greater than 1 week? 1 month? 3 months?&...
Would you treat the involved site or involved field for definitive intent?
For example, in a young patient where standard fields would be very large and you want to minimize toxicity
This patient has previously been treated with low dose total skin electron therapy.
What if it is a young patient?
In this scenario, is systemic treatment better given bilateral involvement? In a patient who has already had cataract surgery and is not at risk for c...
Does your dose recommendation change if a patient has cord compression or has undergone surgery? There is a range of doses in the ILROG guidelin...
At what point would you recommend transfusion? At what point would you stop radiation?
The patient received R-EPOCH followed by consolidative RT (36 Gy in 18 fractions) approximately one year ago and was subsequently salvaged with RICE.
If so, what dose would you recommend?
At what age would you treat an early stage hodgkins lymphoma patient with ABVD + RT (adult treatment) vs OEPA x 2 or AV-PC x 3 (pediatric paradigm)?&n...
How do you decide between WBRT, maintenance chemotherapy, or stem cell transplantation?
The unfavorable risk factors for stage I-II Classic Hodgkin's Lymphoma differ depending on the cooperative group (GHSG, EORTC, NCCN), which criteria d...
Guidelines indicate RCHOPx3 +RT as category I and RCHOP x 6 below that; long term f/u for SWOG 8736 showed similar PFS and OS. Do you have and approac...
For a stage IAE DLBCL (in this case, of the oral cavity) that was completely excised, s/p R-CHOP, is the ISRT target volume just the preop volume plus...
How would your dose and/or volume change if the patient refuses chemotherapy?
Any experience treating patients prone with openings for both breasts, no minimize breast overlap with axilla and mediastinum?
The patient is not a transplant candidate due to multiple co-morbidities. Some of the sites in question have had a complete response and other have ha...
The patient has no bone marrow involvement.
Some specific questions:
Would you recommend repeat biopsy to confirm residual disease?
How would your recommendations vary if the patient had pre...
If the breast was previously radiated 15 years ago, would that change your decision?
If there was residual lymphoma on cytology of a chronic se...
Would you recommend RCHOP x 3-6 or RCHOP x 3 + ISRT? If you end up doing ISRT, would your target be any different than the principles that guide...
Is your scoring based on SUV uptake vs the subjective interpretation of the radiologist? How do you go about reconciling Deauville scoring when there ...
Repeat EGD and additional biopsies of the stomach were all negative for MALT lymphoma and H. Pylori. A CT of the C/A/P was done showing no evidence of...
For example, would you go ahead with 20 Gy of ISRT if medical oncology has already treated a stage I-IIA patient with 2 cycles of ABVD meeting all oth...
If they are symptomatic do you relax that time interval? Do you ever consider partial brain radiation instead of whole brain to minimize neurotoxicity...
In a patient who absolutely cannot receive chemotherapy due to impaired performance status, what dose would you use for WBRT and what dose would you u...
Prior trials of systemic therapy including alkylating agents and rituximab have failed and the patient is medically inoperable with no history of Hepa...
The staging bone marrow biopsy was negative. The staging manual simply states "bone involvement is identified using appropriate imaging studies."...
Would you use a similar dose and fractionation as gastric MALT (30Gy in 1.5 Gy fractions)?
Should prechemo PET positive disease from bowel or other structures be carved out?
Do you generally always boost the scalp and/or soles even if those sites are not involved with disease?
The patient had a bilateral orchiectomy (pathology demonstrated no invasion of the tunica) followed by R-CHOP x 6 and IT Mtx with a PET CR in a para-a...
The patient is a 75 yo immunocompetent man who has a history of inverted papilloma of the sinuses and presented with a new lesion in the right maxilla...
Would you use 10 Gy in 1 Gy per fraction as mentioned in a litterature review in Pubmed?
What factors influence your choice to treat as well as dose and target?
The patient does have significant weight loss, drenching night sweats, but no evidence of other involved sites on PET, thorough skin exam, and has nor...
In the case of an excised groin node with no residual disease and no chemotherapy in a young adult patient, how large should the fields be? Is it requ...
I have a patient with low volume disease of Castleman's disease with cervical lymphadenopathy and tonsillar hyperplasia that is suspicious but not bio...
If a patient has an increase in PET avidity between the PET/CT done after 2 cycles of ABVD and after completion of chemo, how would you proceed? Would...
Does your follow-up differ depending on the dose you used (e.g. boom boom vs. 24 Gy)? Do you routinely image? If so, do you use MRI or PET...
If the patient had a CR by PET/CT after 2 cycles of ABVD and received 6 cycles of ABVD would you recommended consolidating only the bulky disease and ...
What technique do you use (IMRT vs direct electrons w bolus)?
The ILROG paper on extranodal NHL says "For tumors confined to the conjunctiva or...
If a patient will receive a total of 4 cycles ABVD and has a CR by PET/CT after cycle 2, can RT be omitted to non-bulky sites to avoid toxicity?
What dose and volumes would you use?
PET/CT/bone marrow biopsy negative for evidence of distant disease. Following 4 cycles of combination chemotherapy with no evidence of progressive dis...
For example: would you treat the entire Waldeyer's ring? For a stage II patient who also has cervical lymph node involvement on one side, do you...
We often see young women with favorable, early stage disease in the mediastinum who have had a complete response to chemotherapy. With current smaller...
How have the results of the UK RAPID study (Radford et al NEJM 2015) changed your practice?
Specifically, is there still a role for dd RCHOP followed by ICE, or do you recommend DA-R-EPOCH for all patients?
What is the best evidence to support or refute this?
Would you include one vertebral body above and below the involved vertebral body? Is IMRT appropriate in order to reduce dose to small bowel? What oth...
If a patient had recently completed R-EPOCH x 6 cycles, would you change your dose for a low grade follicular lymphoma?
Is surgery an adequate treatment for Stage IE DLBCL of the cervix?
When treating with radiation therapy, what dose-fractionation do you typically utilize?
The NCCN guidelines recommend all patients receive 3 cycles RCHOP followed by ISRT unless they have bulky disease greater than 7.5 cm. However, are th...
With the field moving more toward ISRT/ INRT, and conformal radiation, would you generate separate PTV for initial nodal involvements that are within ...
If so, what data should be presented to insurance companies to cover the cost?
What dose do you recommend?
When nodal regions not amenable to biopsy but are enlarged without significant SUV uptake, should they be treated as involed and recieve RT?
After ABVE-PC X4 and Ifos/vinorelbine x 2 per AHOD 0831 (and is unable to have these sites biopsied), what dose would you treat to and what volume wou...
Is there a preferred low dose splenic irradiation regimine?
When radiation therapy is utilized, what should the radiation therapy treatment fields include and what imaging studies should be completed to assist ...
If so, should involved site radiation thearpy (ISRT) or involved field radiation therapy (IFRT) be used for the radiation therapy treatment fields? Wo...
Are the results of AHOD0031 practice changing?
When the disease (in this case, lymphoma) involves almost all of the entire muscle compartment of the distal lower extremity, what is a safe dose? I'm...
In drawing the lung blocks approximately 1 cm in from the chest wall, diaphragm and mediastinum, should the blocks stop underneath the clavicle o...
If a patient with stage I, low grade follicular lymphoma achieves a complete response after rituxan and treanda is there any role for consolidative ra...
Specifically for marginal zone or follicle center?
Is it necessary to treat the whole orbit or is conformal treatment ok?
After a nerve sparing parotidectomy, would you offer postoperative radiotherapy? If so, what volume and dose? Would it change your management if the p...
In a patient with Stage IE DLBCL, is your treatment volume postchemo ISRT or whole breast? Would you consolidate if a lumpectomy was performed prior t...
Hoskin et al (Lancet Oncology 2014) suggest 24Gy/12fx is more effect RT dose compared to 4Gy.
Is there a benefit to IMRT when we treat to relatively low doses (as compared to squamous cell cancers of the head and neck)?
Or is it more appropriate for certain sites/stages/histologies?
Specifically, for a diffuse large B cell lymphoma of the femur?
It seems that with the arms up, you get better lung blocking but with arms akimbo, you might have a lower dose to the humeral head.
22212221661880214372174021476234921749110822163920629214881785325532088310686206062056120348203531982119162193161656819096191334201190041877818911140191725618574500597891021124731587917409181461736817337173331715813411797817088173341785017769135441747417419173011725017145488495163801628815862157711570915675291715496154633789149051392614635144291269914126140261373513845138521366213377205713098130211287910789126171271512418123861215612124119391188120131173455826909115551160922711142211366111651122281931090710571103831036258716341424910034102499728912196939430968589859460204990088792916390117588943888360878852880083938557850218416211619374666356603783758010822579617647753071967121694116396788638944861606106614856525658469358735804550254785394187452625341404028165030497048444236484244824668459488543405404290387336173357322332183280847312230723084293327142604241923842158867139018111754161114731437145113941348124510091008887934862888797796518681680660521631402627546526507500329485414377359342336331341
Papers discussed in this category
Int. J. Radiat. Oncol. Biol. Phys., 2011-07-15
International journal of radiation oncology, biology, physics, 2014-07-15
International journal of radiation oncology, biology, physics, 2014-05-01
Lancet Oncol., 2014-04-01
J. Clin. Oncol., 2014-04-10
J. Clin. Oncol., 2013-11-10
Oncology (Williston Park, N.Y.), 2012-12
N. Engl. J. Med., 2010-08-12
The New England journal of medicine, 2013-04-11
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-11-10
Practical radiation oncology, 2015
International journal of radiation oncology, biology, physics, 2015-05-01
J. Clin. Oncol., 2015-09-10
Cancer, 2004-08-15
Br. J. Haematol., 2003-11-01
Br. J. Haematol., 1998-08-01
Cancer, 1990-11-15
Radiother Oncol, 1990-01-01
International journal of radiation oncology, biology, physics, 2015-05-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-10-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-05-10
The New England journal of medicine, 1998-07-02
Annals of internal medicine, 1994-06-01
The New England journal of medicine, 2016-06-23
J Clin Oncol, 2020 Sep 18
Blood advances, 2021 Nov 09
Journal of palliative medicine, 2015-07
Turk J Med Sci,
Radiat Oncol, 2015-03-28
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01
Int. J. Radiat. Oncol. Biol. Phys., 2017-01-01
International journal of radiation oncology, biology, physics, 2008-08-01
International journal of radiation oncology, biology, physics, 2015-05-01
International journal of radiation oncology, biology, physics, 2015-05-01
Ann. Oncol., 1996-09-01
International journal of radiation oncology, biology, physics, 2013-03-01
Int. J. Radiat. Oncol. Biol. Phys., 2009-05-01
Int. J. Radiat. Oncol. Biol. Phys., 1983-10-01
Clinical lymphoma, myeloma & leukemia, 2014-12
Advances in radiation oncology, 2019
Int J Radiat Oncol Biol Phys, 2021 Feb 10
Cancer, 2004-05-15
Lancet, 2020 Apr 28
N. Engl. J. Med., 2015-04-23
Leuk. Lymphoma, 2007-09-01
American journal of hematology, 2016-05
Journal of the American Academy of Dermatology, 2016-11
Leukemia & lymphoma, 2014-04
Cancer, 1994-01-01
Med. Pediatr. Oncol.,
Arch. Dis. Child.,
Pediatric blood & cancer, 2018-05
Br. J. Haematol.,
Leuk. Lymphoma,
Blood,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-01-01
Blood,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-05-10
Int. J. Radiat. Oncol. Biol. Phys., 2012 Jun 05
Leukemia & lymphoma, 2017-04
Cancer, 2010-08-15
Journal of the American Academy of Dermatology, 2015-02
Int. J. Radiat. Oncol. Biol. Phys., 2017 Jun 09
Cancer treatment reviews, 2017-02
Radiother Oncol, 2011 Jun 12
Int. J. Radiat. Oncol. Biol. Phys., 2012 Mar 13
Arch. Pathol. Lab. Med.,
Int. J. Radiat. Oncol. Biol. Phys.,
Mediterr J Hematol Infect Dis, 2017 Apr 15
Annals of oncology : official journal of the European Society for Medical Oncology, 2011-02
Clinical lymphoma, myeloma & leukemia, 2019-08
Cancer,
Annals of oncology : official journal of the European Society for Medical Oncology, 2007-04
Cancer, 2015-04-01
Oncology (Williston Park, N.Y.), 2014-12
International journal of radiation oncology, biology, physics, 2018-07-15
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-07-10
J Clin Oncol, 2020 Jul 13
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-09-01
J. Clin. Oncol., 2019 Sep 10
International journal of radiation oncology, biology, physics, 2018-09-01
Cancer Treat Rep,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-07-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-03-20
J. Clin. Oncol.,
Leukemia & lymphoma, 2017-12
Int. J. Radiat. Oncol. Biol. Phys., 2012 Jul 24
, 2016 Apr 26
American journal of clinical oncology, 1992-10
European journal of haematology, 2005-11
Radiat Oncol, 2019 Apr 15
Clinical lymphoma, myeloma & leukemia, 2019-04
Head Neck, 2017 Apr 03
Leuk Lymphoma, 2019 Aug 02
Annals of oncology : official journal of the European Society for Medical Oncology, 2017-05-01
Cancer research, 2017-07-15
Radiother Oncol, 2008 Feb 20
Int J Radiat Oncol Biol Phys, 2019 Nov 07
Int J Radiat Oncol Biol Phys,
J Clin Oncol,
Blood, 2011-10-06
Practical radiation oncology, 2011
Cancer, 1989-06-01
Cancer, 1985-06-01
J Cancer Res Clin Oncol, 2017 Jan 16
Int J Radiat Oncol Biol Phys,
J Neurooncol, 2020 Apr
Cureus, 2016 Jul 18
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-08-01
N Engl J Med,
J Clin Oncol, 2007 Jan 16
Ann Oncol,
The New England journal of medicine, 2016-07-14
Practical radiation oncology, 2021 Sep-Oct
Palliative medicine, 2022 Mar 31
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Mar 28
Strahlenther Onkol, 2017 Jun 01
International journal of radiation oncology, biology, physics, 2019-12-01
The Lancet. Oncology, 2019-01
Molecular therapy : the journal of the American Society of Gene Therapy, 2018-11-07
Cancer immunology research, 2019-07
Br J Haematol, 2020 Mar 5
Lancet, 2020 Sep 01
Blood Adv,
Int J Radiat Oncol Biol Phys, 2020 May 22
The New England journal of medicine, 2017-12-28
Radiother Oncol, 2021 Dec 7
Int J Radiat Oncol Biol Phys, 2021 Dec 1
Int J Radiat Oncol Biol Phys, 2022 Dec 20
Transplant Cell Ther, 2022 Dec 30
Blood advances, 2020 Jul 28
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022 Oct 26
Blood advances, 2020 Nov 24
Haematologica, 2023 Jun 15
Annals of oncology : official journal of the European Society for Medical Oncology, 2009-11
Eur J Haematol, 2020 Aug 19
Arthritis care & research, 2018-10
Cancers (Basel), 2020 Apr 17
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-06-01
J Clin Neurosci, 2018 Nov 12
Br J Haematol,
Neuro Oncol, 2007 May 23
Lancet,
N Engl J Med, 2021 Dec 11
Lancet,
Eur J Nucl Med Mol Imaging, 2016 May 07
Int J Radiat Oncol Biol Phys, 2021 Mar 24
International journal of radiation oncology, biology, physics, 2019-09-01
BMC Cancer, 2010 Aug 09
Ann Oncol,
International journal of radiation oncology, biology, physics, 2018-04-01
International journal of radiation oncology, biology, physics, 2001-01-01
Int J Radiat Oncol Biol Phys,
Leukemia, 2022 Jun 22
Chin Med J (Engl), 2008 May 20
Urol Ann, 2015 Oct-Dec
J Clin Oncol, 2010 Aug 02
Journal of the National Cancer Institute, 2016-06
Pediatrics, 2014 Feb 02
N. Engl. J. Med.,
The Journal of urology, 2018-12
N. Engl. J. Med.,
Lancet Oncol., 2014 Feb 18
NEJM Evidence, 2022 Jun 1
Br J Cancer, 2014 Apr 15
Cancer, 2011-06-15
Eur J Cancer, 2017 Nov 28
N. Engl. J. Med., 2019 Sep 28
Lancet Oncol, 2021 Jan 18
J Clin Oncol, 2021 Apr 19
J Clin Oncol, 2003 Jul 01
JAMA, 2019 Apr 16
Head Neck, 2016 Mar 29
The Lancet. Oncology, 2017-05
Journal of the National Cancer Institute, 2013-08-21
Journal of the National Cancer Institute, 2018-01-01
JAMA oncology, 2021 May 01
Antioxidants & redox signaling, 2020 Aug 07
Journal of experimental & clinical cancer research : CR, 2020 Oct 07
BMJ (Clinical research ed.), 2000 Nov 04
Human vaccines & immunotherapeutics, 2017 Feb
J Hematol Oncol, 2022 Mar 26
Blood advances, 2022 May 10
Leukemia & lymphoma, 2018-12
Annals of oncology : official journal of the European Society for Medical Oncology, 2008-02
Radiother Oncol, 2020 Oct 14
The Lancet. Haematology, 2021 Feb
Blood, 2023 Nov 30
Cancer, 2011-10-01
BMC Cancer, 2006 May 05
International journal of radiation oncology, biology, physics, 1998-07-15
International journal of radiation oncology, biology, physics, 2006-01-01
Blood, 2014 May 29
Blood, 2014 Jun 17
International journal of radiation oncology, biology, physics, 2011 Jan 27
J Clin Oncol, 2022 Jul 22
The New England journal of medicine, 2022 Jul 13
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998 Mar
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-05-10
Neurooncol Adv, 2023 Jan-Dec
Journal of the Endocrine Society, 2022 Dec 02
Diagnostics (Basel, Switzerland), 2021 Apr 20
Practical radiation oncology, 2022 Sep 08
N Engl J Med, 2022 Nov 03
The New England journal of medicine, 2024 Oct 17
J Clin Oncol, 2021 Apr 07
International journal of radiation oncology, biology, physics, 2024 Oct 27
Scientific reports, 2022 Nov 29
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-12-10
Blood, 2015 Jun 24
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009 Oct 05
J Clin Oncol, 2017 Mar 14
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Feb 15
The Lancet. Oncology, 2021 Feb